Katie Bullock

2PUBLICATIONS
29CO-AUTHORS
Medical virologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

|Mar 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Tim Rowland, Richard FitzGerald, Elizabeth Challenger

Pageof 1

Frequent Collaborators

2 joint publications

Richard FitzGerald

2 joint publications

Thomas Jaki

2 joint publications

Pavel Mozgunov

2 joint publications

Laura J Else